Alemtuzumab following natalizumab in pediatric- and adult-onset multiple sclerosis

Young Investigator
Marta Gaggiola
43
Padua, Italy

Downloads

43 ECF2022 Abstract TR Gaggiola M ( 669 KB, pdf)